IDB Resources will offer Paradigm Diagnostics' PCDx NGS tumor profiling test in Malaysia, Singapore, and Brunei.
Strata said it will use the funds to implement the Strata Trial, a nationwide effort to increase the number of enrollments in precision medicine clinical trials.
Genetic Alliance researchers have come up with recommendations for the UK's NHS on how to incorporate whole-genome sequencing into standard cancer care.
Researchers from St. Jude Children's and the German Cancer Research Center used methylation and gene expression analyses to uncover the subtypes.
The Belgian cancer diagnostics firm will provide the lab with access to its OncoDeep DX Plus and Clinical Plus services.
Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.
The researchers performed targeted sequencing using Thermo Fisher Scientific's Oncomine Comprehensive Panel and the Ion Torrent PGM or Proton.
The partners will develop an NGS panel for solid and liquid tumors for use in personalized oncology.
Reimbursement from private insurers continues to grow, with United Healthcare recently saying it will cover molecular profiling for stage IV non-small cell lung cancer patients.
Under the terms of the agreement, N-of-One will provide clinical interpretation services for samples sequenced on a 50-gene hot-spot solid tumor panel.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.